Sociologist Jessica Calarco explains why the right keeps winning, and how progressive narratives can turn the tide ...

The Senate confirmed two of President Donald Trump’s health nominees Tuesday evening, largely along party lines, in a win for ...

The U.S. dropped to its lowest-ever place on a list of the happiest countries to live in, according to an annual survey ...

Sydney Emerson and Sara Satko of Porterville are among the artists whose art is feature in the annual Tulare County Farm ...

A large majority of older Americans feel that health insurance – including Medicare – should cover anti-obesity medications, according to a new University of Michigan study.

A new medical database automatically compiles the medical records of obese patients and those suffering from obesity-related diseases in a uniquely comprehensive and reliable manner.

Market Analysis and Sales Forecast" report has been added to ResearchAndMarkets.com's offering. Across the 68 markets, sales in the obesity market were $12.3 billion in 2021, growing to $206.5 billion ...

Novo Nordisk’s hopes of heralding a new era of obesity treatment with its next-generation CagriSema drug may be in doubt ...

Novo Nordisk is taking aim at Eli Lilly with a new obesity drug deal. Meanwhile, a survey shows doctors’ perception of the ...

Setmelanotide is a melanocortin-4 receptor (MC4R) agonist designed to treat hyperphagia and obesity. Rhythm is evaluating setmelanotide in a global Phase 3 trial in patients with acquired hypothalamic ...

The licensing pact adds a second so-called "triple agonist" to the Danish drugmaker's portfolio as competition with Lilly and ...

Novo Nordisk’s (NVO) stock has dropped by 25% in March (on the Copenhagen exchange) to put it on track for its biggest ...